Michel Barrois

Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

Claude Houdayer, Virginie Caux‐Moncoutier, Sophie Krieger et al. · Human Mutation · 2012 · 238 citations

PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor

Agnès Chompret, Caroline Kannengiesser, Michel Barrois et al. · Gastroenterology · 2003 · 236 citations · Full text

Tumor Biology, Pdgfra Germline Mutation, Somatic Variant +11

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

J.C. Ahomadegbe, Michel Barrois, Sandy Fogel et al. · PubMed · 1995 · 198 citations

Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

Valérie Boige, Jean Mendiboure, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2010 · 165 citations · Full text

Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults

Aurélie Pétain, Darouna Kattygnarath, Julie Azard et al. · Clinical Cancer Research · 2008 · 160 citations